The U.S. FDA is poised to propose a significant change to the Generally Recognized as Safe (GRAS) framework that could reshape how food and feed ingredients are brought to market. Under the agency’s planned rulemaking, manufacturers would be required to submit GRAS notifications to the FDA for substances intended for use in human and animal food, potentially ending the long-standing practice of self-affirmed GRAS determinations without FDA notification. 

Join our webinar to learn what the proposed mandatory GRAS notification requirement could mean for ingredient manufacturers, food producers, and regulatory compliance teams. We will explore the current regulatory landscape, expected changes, potential business impacts, timelines for implementation, and practical steps organizations can take now to prepare for a more transparent and FDA-centered GRAS review process.

Key topics include:

  • Overview of the current GRAS notification program and self-affirmation pathway
  • Details of the FDA’s proposed mandatory notification framework
  • Potential implications for new and existing ingredients
  • Regulatory, legal, and commercial considerations for industry stakeholders
  • Strategies for compliance readiness and risk mitigation

15 September 2026 | 10am EDT, 2pm GMT, 4pm CEST

By completing this form, you submit your information to the webinar organizer, who will use it to communicate with you regarding this event and their other services.